BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16242818)

  • 1. Interferon-gamma production in vitro from whole blood of foot-and-mouth disease virus (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV.
    Parida S; Oh Y; Reid SM; Cox SJ; Statham RJ; Mahapatra M; Anderson J; Barnett PV; Charleston B; Paton DJ
    Vaccine; 2006 Feb; 24(7):964-9. PubMed ID: 16242818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An MHC-restricted CD8+ T-cell response is induced in cattle by foot-and-mouth disease virus (FMDV) infection and also following vaccination with inactivated FMDV.
    Guzman E; Taylor G; Charleston B; Skinner MA; Ellis SA
    J Gen Virol; 2008 Mar; 89(Pt 3):667-675. PubMed ID: 18272757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of carriers of foot-and-mouth disease virus among vaccinated cattle.
    Moonen P; Jacobs L; Crienen A; Dekker A
    Vet Microbiol; 2004 Nov; 103(3-4):151-60. PubMed ID: 15504586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ T-cell responses to foot-and-mouth disease virus in vaccinated cattle.
    Carr BV; Lefevre EA; Windsor MA; Inghese C; Gubbins S; Prentice H; Juleff ND; Charleston B
    J Gen Virol; 2013 Jan; 94(Pt 1):97-107. PubMed ID: 23034593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory IgA as an indicator of oro-pharyngeal foot-and-mouth disease virus replication and as a tool for post vaccination surveillance.
    Parida S; Anderson J; Cox SJ; Barnett PV; Paton DJ
    Vaccine; 2006 Feb; 24(8):1107-16. PubMed ID: 16203061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model.
    Neilan JG; Schutta C; Barrera J; Pisano M; Zsak L; Hartwig E; Rasmussen MV; Kamicker BJ; Ettyreddy D; Brough DE; Butman BT; Brake DA
    BMC Vet Res; 2018 Aug; 14(1):254. PubMed ID: 30157853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of foot-and-mouth disease virus infected animals from vaccinated animals using a blocking ELISA based on baculovirus expressed FMDV 3ABC antigen and a 3ABC monoclonal antibody.
    Sørensen KJ; de Stricker K; Dyrting KC; Grazioli S; Haas B
    Arch Virol; 2005 Apr; 150(4):805-14. PubMed ID: 15645377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Foot-and-Mouth Disease Carrier State Divergence in Cattle.
    Stenfeldt C; Eschbaumer M; Rekant SI; Pacheco JM; Smoliga GR; Hartwig EJ; Rodriguez LL; Arzt J
    J Virol; 2016 Jul; 90(14):6344-64. PubMed ID: 27147736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foot-and-mouth disease vaccination induces cross-reactive IFN-γ responses in cattle that are dependent on the integrity of the 140S particles.
    Bucafusco D; Di Giacomo S; Pega J; Schammas JM; Cardoso N; Capozzo AV; Perez-Filgueira M
    Virology; 2015 Feb; 476():11-18. PubMed ID: 25496826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic immune response and virus persistence after foot-and-mouth disease virus infection of naïve cattle and cattle vaccinated with a homologous adenovirus-vectored vaccine.
    Eschbaumer M; Stenfeldt C; Rekant SI; Pacheco JM; Hartwig EJ; Smoliga GR; Kenney MA; Golde WT; Rodriguez LL; Arzt J
    BMC Vet Res; 2016 Sep; 12():205. PubMed ID: 27634113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a chemiluminescence immunoassay using recombinant non-structural epitope-based proteins to accurately differentiate foot-and-mouth disease virus-infected and vaccinated bovines.
    Liu ZZ; Zhao FR; Gao SD; Shao JJ; Zhang YG; Chang HY
    Transbound Emerg Dis; 2018 Apr; 65(2):338-344. PubMed ID: 29341485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an epitope-blocking-enzyme-linked immunosorbent assay to differentiate between animals infected with and vaccinated against foot-and-mouth disease virus.
    Oem JK; Chang BS; Joo HD; Yang MY; Kim GJ; Park JY; Ko YJ; Kim YJ; Park JH; Joo YS
    J Virol Methods; 2007 Jun; 142(1-2):174-81. PubMed ID: 17336400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.
    Pan L; Zhang Z; Lv J; Zhou P; Hu W; Fang Y; Chen H; Liu X; Shao J; Zhao F; Ding Y; Lin T; Chang H; Zhang J; Zhang Y; Wang Y
    Int J Nanomedicine; 2014; 9():5603-18. PubMed ID: 25506214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological and mucosal immune responses after vaccination and infection with FMDV in pigs.
    Eblé PL; Bouma A; Weerdmeester K; Stegeman JA; Dekker A
    Vaccine; 2007 Jan; 25(6):1043-54. PubMed ID: 17157418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge.
    Schutta C; Barrera J; Pisano M; Zsak L; Grubman MJ; Mayr GA; Moraes MP; Kamicker BJ; Brake DA; Ettyreddy D; Brough DE; Butman BT; Neilan JG
    Vaccine; 2016 Jun; 34(27):3214-3220. PubMed ID: 26707216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
    Singanallur NB; Pacheco JM; Arzt J; Stenfeldt C; Fosgate GT; Rodriguez L; Vosloo W
    Antiviral Res; 2017 Sep; 145():114-122. PubMed ID: 28780422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle.
    Cox SJ; Voyce C; Parida S; Reid SM; Hamblin PA; Hutchings G; Paton DJ; Barnett PV
    Vaccine; 2006 Apr; 24(16):3184-90. PubMed ID: 16488060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.
    Capozzo AV; Wilda M; Bucafusco D; de los Ángeles Lavoria M; Franco-Mahecha OL; Mansilla FC; Pérez-Filgueira DM; Grigera PR
    Antiviral Res; 2011 Nov; 92(2):219-27. PubMed ID: 21889542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
    Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
    J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparable sensitivity and specificity in three commercially available ELISAs to differentiate between cattle infected with or vaccinated against foot-and-mouth disease virus.
    Moonen P; van der Linde E; Chénard G; Dekker A
    Vet Microbiol; 2004 Apr; 99(2):93-101. PubMed ID: 15019100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.